MyAverix Finance
SHE · Healthcare
Walvax BioTech (300142)
Drug Manufacturers - Specialty & Generic
Walvax BioTech (300142) is listed on SHE in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-03-23, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 300142
Walvax BioTech (300142) — FAQ
What is 300142's P/E ratio?
The price-to-earnings (P/E) ratio for Walvax BioTech (300142) is 18.00 (data as of 2026-03-23).
Does Walvax BioTech pay a dividend?
Dividend yield is not available in the current snapshot for Walvax BioTech (300142). Check the MyAverix Finance app for the latest dividend data.
What sector is Walvax BioTech in?
Walvax BioTech (300142) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
What exchange is 300142 listed on?
300142 is listed on SHE.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.